Legal Representation
Attorney
WILLIAM D O'NEILL
USPTO Deadlines
Next Deadline
951 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1998-06-16)
Due Date
June 16, 2028
Grace Period Ends
December 16, 2028
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 21, 2009 | CAEX | O | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | Loading... |
| Oct 20, 2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 9, 2005 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Mar 19, 2005 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
| Jan 31, 2005 | I | PAPER RECEIVED | Loading... | |
| Jan 31, 2005 | PR23 | I | RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 15 | Loading... |
| Jan 31, 2005 | AMD7 | I | SEC 7 REQUEST FILED | Loading... |
| Jul 30, 2004 | PR23 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | Loading... |
| Jun 21, 2004 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | Loading... |
| Jun 16, 1998 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 27, 1998 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 22, 1998 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 20, 1998 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 16, 1998 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 30, 1997 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 10, 1997 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Feb 4, 1997 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 4, 1997 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 6, 1996 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 3, 1996 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Nov 7, 1996 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Additional Information
Other
In the statement, column 1, line 1, "FLEMING AND COMPANY" should be deleted, and, "FLEMINT AND COMPANY, PHARMACEUTICALS" should be inserted.